NCT02802085View on ClinicalTrials.gov

VEGA Prospective Kiel

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Degenerative OsteoarthritisRheumatoid Arthritis
Interventions
DEVICE

VEGA Knee

TKA

Trial Locations (1)

24119

MEDBALTIC GmbH c/o Mare Klinikum, Kiel

All Listed Sponsors
collaborator

Frictionless GmbH

UNKNOWN

lead

Aesculap AG

INDUSTRY

NCT02802085 - VEGA Prospective Kiel | Biotech Hunter | Biotech Hunter